MedTrace Logo

Sonographic Examination of Median Nerve Variations

NCT06538779 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2025-05-30

No results posted yet for this study

Summary

The aim of the study is to evaluate the prevalence of bifid median nerve in patients diagnosed with carpal tunnel syndrome (CTS) and whether it has a higher prevalence in CTS patients than in asymptomatic individuals, and to evaluate the characteristics of the bifid median nerve found and whether median nerve variations are predisposing factors in the development of CTS.

Conditions

  • Carpal Tunnel Syndrome

Interventions

DIAGNOSTIC_TEST

elastography,usg

Patients' general pain will be assessed with Visual Analog Scale (Global Pain), symptom severity and functional status will be assessed with Boston Carpal Tunnel Questionnaire, hand grip strength will be measured with dynamometer. Patient hand diagram will be marked according to patient's sensory symptoms. Median nerve cross-sectional area measurement at pisiform level with ultrasound, distal motor latency and sensory nerve conduction velocity with emg will be performed and recorded. Median nerve stiffness will be assessed with real-time elastography.

Sponsors & Collaborators

  • Yunus Burak Bayır

    lead OTHER_GOV

Principal Investigators

  • Başak MANSIZ KAPLAN, assoc. prof. · Ankara Etlik City Hospital

  • Ebru KARACA UMAY, prof. dr. · Ankara Etlik City Hospital

  • Ajda BAL, prof. dr. · Ankara Etlik City Hospital

  • Selin ÇELEBİER, assistant dr · Ankara Etlik Şehir Hastanesi

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2025-09-01
Completion
2025-09-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06538779 on ClinicalTrials.gov